Retrospective analysis shows high resistance to third-generation cephalosporins in Klebsiella pneumoniae, indicating urgent action for antibiotic stewardship.
Key Points
Over 69% of Klebsiella pneumoniae isolates were resistant to third-generation cephalosporins, emphasizing the healthcare challenge.
More than 92% of isolates showed sensitivity to carbapenems, presenting a critical treatment option for resistant infections.
The highest burden of K. pneumoniae infections was in patients aged 51–70 years, indicating a vulnerable demographic for antibiotic resistance.
Judicious use of antibiotics is crucial for managing rising resistance rates and ensuring effective treatment options are available.